Yunqi Capital opposes STAAR Surgical merger despite Alcon's raised bid
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Yunqi Capital Comments on STAAR Surgical’s Go-Shop Process and Alcon’s Revised Offer
December 10, 2025 7:05 AM ESTBelieves STAARs Sale Process Was Structured to Seal the Alcon Deal, Not to Maximize Value for Shareholders
The Company Is Not Ripe for Sale at This Time
Continues to Urge STAAR Shareholders to Vote AGAINST the Proposed Transaction
HONG KONG--(BUSINESS WIRE)-- Yunqi Capital Limited (together with its affiliates and the funds it advises, Yunqi Capital), an investment management firm and 5.1% shareholder of STAAR Surgical Company (STAAR or the Company) (NASDAQ: STAA), today released the following letter to STAAR... More



